World Sepsis Day 2024 highlights need for better sepsis treatments
PharmaTimes
by John Pinching
2d ago
GlobalData emphasises importance of Improved clinical trials ..read more
Visit website
Nxera and Cancer Research UK to present promising cancer drug trial at ESMO
PharmaTimes
by John Pinching
2d ago
Innovative immunotherapy drug HTL0039732 shows potential in trials ..read more
Visit website
HRT linked to reduced psychosis relapse risk in menopausal women
PharmaTimes
by John Pinching
3d ago
New study highlights potential benefits of menopausal hormone therapy ..read more
Visit website
Centessa reports positive phase 1 clinical data for ORX750
PharmaTimes
by John Pinching
3d ago
Promising results for novel orexin agonist in sleep-deprived volunteers ..read more
Visit website
Scotland first in UK to approve new myeloma treatment
PharmaTimes
by John Pinching
4d ago
Patients with relapsed multiple myeloma gain access to life-extending therapy ..read more
Visit website
AI-Powered chest X-Rays detect lung cancer early
PharmaTimes
by John Pinching
4d ago
New evidence highlights AI’s potential in early lung cancer detection ..read more
Visit website
Phase 2 PREDICT-ILD imaging study commences in interstitial lung disease
PharmaTimes
by John Pinching
5d ago
Molecular imaging agent 99mTc-maraciclatide to aid in disease prognostication ..read more
Visit website
APL and CurifyLabs partner to support patients with 3D printing medicine technology
PharmaTimes
by John Pinching
5d ago
Critically ill individuals will benefit from futuristic tech ..read more
Visit website
ChatGPT outperforms trainee doctors in assessing respiratory illness in children
PharmaTimes
by John Pinching
5d ago
Research suggests that LLMs could be used to support trainee doctors, nurses and GPs ..read more
Visit website
Eli Lilly’s once-weekly insulin shows promise in phase 3 trials
PharmaTimes
by John Pinching
1w ago
New treatment could simplify diabetes management for millions ..read more
Visit website

Follow PharmaTimes on FeedSpot

Continue with Google
Continue with Apple
OR